Journal of Heart and Lung Transplantation

Article	Citations
Information for Readers	479
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	337
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	272
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	204
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	150
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	131
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	116
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	110
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	84
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	77
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	69
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	67
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	60
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	60
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	58
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	57
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	56
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	54
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	51
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	51
Hemodynamic Modeling for Mitral Regurgitation	49
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	48
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	48
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	45
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	43

(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	41
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	41
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	40
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	40
ISHLT 2023 Author Index	40
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	40
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	39
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	38
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	37
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	37
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	37
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	37
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	36
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	35
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	35
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	35
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	34
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	34
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	33
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	33
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	33
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	31
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	31
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	31
(911) Older Donors in Lung Transplantation: The Portuguese Experience	31
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	31
Comparison of LVAD Admissions Before and During the Era of COVID-19	31
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	31
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	31
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	30
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	30
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	29
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	29
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	29
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	29
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	28
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	28
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	28
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	28
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	28
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	28
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	27
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	27
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	27
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	27
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	26
Information for Readers	26
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	26
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	26
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	26

Not just for the birds: The emerging role of B cells in transplant immunology	26
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	26
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	25
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	25
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	25
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	25
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	25
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	25
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	24
Early Onset Malignancy in the First-Year After Heart Transplantation	24
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	24
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	24
Comparative Analysis of Fontan Transplant Outcomes	23
Older Donor Hearts for Heart Transplantation	23
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	23
Table of Contents	23
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	23
Editorial Board	23
WITHDRAWN	23
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	22
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	22
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	22
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	22
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	21
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	21
Ex-vivo lung perfusion: National trends and post-transplant outcomes	21
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	21
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	21
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	21
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	20
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	20
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	20
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	20
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	20
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	20
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	20
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	20
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	20
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	20
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	20
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	20
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	20
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	20
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	20
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	20
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	19
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	19
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	19
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	18
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	18
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	18
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	18
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	18
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	18
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	18
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	18
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	18
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant	18
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	18
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	18
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	17
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	17
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	17
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	17
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	17
Use of Heart in Donor Death Caused by Lightning	17
Impact of Logistic Challenges on Cardiac Transplantation	17
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	17
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	17
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	17
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	17
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	16
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	16
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	16
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	16
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	16
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	16
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	16
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	16
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	16

Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	16
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	16
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	16
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	16
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	16
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	15
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	15
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	15
First North American Experience with The Berlin Heart Active Driver	15
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	15
Clinical utility of donor-derived cell-free DNA testing in cardiac transplantation	15
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	15
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	15
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	15
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	15
Unlocking the black box of heart preservation	14
Towards a nuanced understanding of donor risk	14
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	14
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	14
Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine	14
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	14
Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor	14
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	14
Knowledge gaps in heart and lung donation after the circulatory determination of death: Report of a workshop of the National Heart, Lung, and Blood Institute	14
I got it from my mamma: Sensitization by transplacental transfer of maternal HLA antibodies managed with manual exchange transfusion	14
Rapid progression of cardiac remodeling and apical wall thinning in early age with hypertrophic cardiomyopathy	14
Life on the driveline: Still finding traction in improving transplant outcomes for children with myocarditis	14
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	14
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis	14
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	14
Risk assessment models and survival in pulmonary arterial hypertension: a SPAHR analysis	14
Risk of Prolonged Intubation Post-Pediatric Heart Transplantation	14
Extra-cardiac management of cardiogenic shock in the intensive care unit	14
Incidence and Risk Factors for Early Stroke Following Durable Left Ventricular Assist Device (LVAD) Implantation: An STS Intermacs Analysis	14
Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review	14
A Rare Case of ACE Inhibitor-Induced Intestinal Angioedema Presenting as a Delayed Complication in a Heart Transplant Recipient	13
(826) Dual VADs to Dual Organs: Successful Bridge to Heart and Kidney Transplantation with 2 HeartMate 3 LVADs in Biventricular Failure	13
Standardized Radiographic Evaluation of Human Donor Lungs During Ex Vivo Lung Perfusion Predicts Lung Injury and Lung Transplant Outcomes	13
Care Close to Home: Justification for a Second Paediatric Heart Transplant Centre in Australia	13
(550) A Retrospective Study on Gender, LAA Morphology and Stroke Risk	13
VAD as Bridge to Transplant Decision in Nine-Year-Old Child with Duchenne Muscular Dystrophy	13
Eplet Matching in Pediatric Heart Transplantation	13
Low AlloSure® in HeartCare® Associated with Low Risk of Significant Allograft Rejection: An Analysis of SHORE	13
Gentle Giant: An Unusual Cause of Heart Block	13
(1191) Diagnostic Utility of Surveillance Transbronchial Biopsies after the First Post-Lung Transplant Year	13
Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension	13
(771) Post-Implant Outcomes in Diabetic vs. Non-Diabetic Durable LVAD Patients	13
(559) Heart Transplantation Using Super Aged Donors at 65 Years and Over	13
Development of De-Novo Aortic Insufficiency in Patients with Durable Left Ventricular Assist Device Who Were Bridged from Impella Device	13
The Role of Anti-Thymocyte Globulin in Peri-Operative Desensitization for Donor Specific Antibody Positive Lung Transplants	13
The United States Experience of Lung Transplantation in Recipients with COVID-19 Fibrosis: A UNOS/OPTN Analysis	13
Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy	13
Peri-Operative Warfarin Protocol to Decrease Length of Stay After Left Ventricular Assist Device Implantation	13
Scimitar Syndrome Outcomes in Patients with Pulmonary Hypertension: A Single Center Experience	12
(686) West Nile Virus Meningoencephalitis in a Bilateral Lung Transplant Recipient	12
(730) Continuous Temperature Measurements in Donor Hearts During Cold Organ Procurement	12
Longitudinal Echocardiographic Assessment of Donor Hearts in DCD Donors Using Thoracoabdominal Normothermic Regional Perfusion	12
PET Scan for CAV Screening in Heart Transplant Patients: A Real World Experience	12
Risks and Outcomes Associated with Pleural Space Infections After Lung Transplantation	12
Long-Term Weaning of Mechanical Ventilation After Lung Transplantation: Patient Characteristics and Impact on Survival	12
(612) Using the SCAI Classification for Early Identification and Real-Time Monitoring of Cardiogenic Shock Patients	12
(647) Utilization of Hepatitis C Virus Infected Donor in Heart Transplant Recipients with Elevated Meld-Xi Score	12
(691) Right Heart Recovery after Lung Transplantation in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome: A Cohort Study	12
(711) Capillary Leak Syndrome Induced by Tacrolimus in Post-Lung Transplant Recipient	12
(859) Concurrent Tracheobronchoplasty and Bilateral Lung Transplant for Obstructive Lung Disease	12
(916) Lung Transplant Outcomes in Young Adults with Pulmonary Hypertension Bridged with ECMO	12
Proposal for Simplified Endoscopic Standardized Grading of Central Airway Complications After Lung Transplantation According to the Long-Term Prognosis Value of the Current MDS Classification	12
(634) Is Off-Pump Coronary Bypass Surgery the Savior of Low EF Coronary Artery Disease Patients?	12
Pulmonary Dead Space Fraction: A Predictive Factor for Transplant Suitability in Clinical Ex Vivo Lung Perfusion	12
Outcomes of Mechanical Circulatory Support for Severe Primary Graft Dysfunction After DBD versus DCD Heart Transplantation	12
Body Mass Index and Cause-Specific Mortality After Lung Transplantation in the United States	12
(817) Lvad-Stem Cell Combination Therapy in Non-Ischemic Dilated Cardiomyopathy Patient: Case Report	12
(921) Effect of Surgical Exposure on Short-Term Outcomes after Bilateral Lung Transplantation	12
Donor and Peri-Transplant Hospitalization Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients	12
(1272) Effect of Aging on the Progression of Pulmonary Ischemia-Reperfusion Injury in Clawn Miniature Swine	11
(933) Mechanical Circulatory Support as a Weaning Platform from Extracorporeal Membrane Oxygenation	11
(439) Severe Biventricular Dysfunction Following Pericardiectomy in a Pediatric Patient	11
Long-Term Survivors Following Pediatric Heart Transplantation: A PHTS Database Analysis	11
(1036) Through the "Chimney": Berlin Heart Excor Pediatric Ventricular Assist Device Inflow Stenting via a Novel Direct Access to Inflow Tubing	11
Artificial Intelligence for the Prognostication and Management of Heart Transplant: A Scoping Review	11
(1014) Super Accelerated Cardiac Allograft Vasculopathy	11
(1246) Novel Regional Ventilation Evaluation of Abnormalities of the Lung In Advanced Lung Disease (REVEAL Study)	11
(956) Chronic in Vivo Animal Data on a Wireless Systolic Synchronized Mini-Cardiac Pump	11
(1247) Rapidly Declining Rates of Single Lung Transplant for COPD and ILD in the U.S	11
Pulmonary Artery Pressures During Cardiopulmonary Exercise Testing Using Cardiomems	11
ACEi Use in Select Patients Awaiting Heart Transplant May Be a Risk Factor for the Development of Primary Graft Dysfunction and Vasoplegia	11
(487) Use of Leadless Cardiac Pacemakers in Heart Transplant Recipients: A Case Series	11
(1013) The Dilemma of the Role of Non-HLA Antibodies in AMR	11
Using mTOR Inhibitor Nanoimmunotherapy to Induce Cardiac Allograft Tolerance in Non-Human Primates	11
Intercostal Nerve Cryoablation as Part of an Opioid-Sparing Protocol Reduces Narcotic and Epidural Use After Lung Transplant	11
Youth Perspectives on Life and Healthcare After Lung Transplant	11
Rapid Donor-Specific Single Nucleotide Variation Detection by Nanopore Sequencing of Ex Vivo Lung Perfusate	11
Effect of Donor Age on Posttransplant Mortality in Pediatric Heart Transplant Recipients: A 10-Year Nationwide Cohort Study	11
Small Anastomotic Dehiscence Identified Late After Lung Transplant	11
Variability in Donor-Derived Cell-Free DNA Levels Predicts Mortality Risk in Heart Transplant Recipients	11